Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
argenx SE - American Depositary Shares
(NQ:
ARGX
)
795.42
+19.16 (+2.47%)
Streaming Delayed Price
Updated: 3:17 PM EDT, May 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
215,173
Open
775.62
Bid (Size)
794.16 (80)
Ask (Size)
796.89 (120)
Prev. Close
776.26
Today's Range
775.62 - 799.69
52wk Range
510.06 - 934.62
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Patient Square Makes a Big Bet on Nektar Pharmaceuticals (NKTR) Purchasing 210,000 Shares
↗
May 16, 2026
This biotech firm develops immunotherapies for cancer and autoimmune diseases, with several candidates advancing through clinical trials.
Via
The Motley Fool
2 Ways to Play the Big Pharma Patent Cliff
↗
May 15, 2026
With hundreds of billions in sales on the line for drugs that will lose their patent exclusivity in the coming years, two biotech ETFs can help capitalize.
Via
MarketBeat
Topics
ETFs
Intellectual Property
Performance
YTD
-5.3%
-5.3%
1 Month
-4.7%
-4.7%
3 Month
-5.7%
-5.7%
6 Month
-14.4%
-14.4%
1 Year
+37.6%
+37.6%
More News
Read More
argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
May 08, 2026
From
argenx SE
Via
GlobeNewswire
argenx Reports First Quarter 2026 Financial Results and Provides Business Update
May 07, 2026
From
argenx SE
Via
GlobeNewswire
argenx to Present at BofA Securities 2026 Health Care Conference
May 06, 2026
From
argenx SE
Via
GlobeNewswire
argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer
May 06, 2026
From
argenx SE
Via
GlobeNewswire
argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
April 30, 2026
From
argenx SE
Via
GlobeNewswire
argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP
April 18, 2026
From
argenx SE
Via
GlobeNewswire
This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story
↗
March 21, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch
↗
March 21, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
argenx announces Annual General Meeting of Shareholders on May 6, 2026
March 20, 2026
From
argenx SE
Via
GlobeNewswire
This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund
↗
March 20, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Complementing the Future: A Deep Dive into Dianthus Therapeutics (DNTH) After Its Phase 3 Breakthrough
March 12, 2026
Via
Finterra
Topics
Economy
DNTH Stock Soars After Early ‘Go’ Decision For Drug In Autoimmune Disorder Program, Boosting Wall Street Optimism For Potential Launch
↗
March 09, 2026
Via
Stocktwits
argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline
March 06, 2026
From
argenx SE
Via
GlobeNewswire
Argenx (ARGX) 2026 Feature: The Anatomy of a Biotech Powerhouse Transitioning to Profitability
February 26, 2026
Via
Finterra
Topics
Earnings
Economy
Intellectual Property
argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
February 26, 2026
From
argenx SE
Via
GlobeNewswire
argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
February 26, 2026
From
argenx SE
Via
GlobeNewswire
argenx to Present at TD Cowen 46th Annual Healthcare Conference
February 23, 2026
From
argenx SE
Via
GlobeNewswire
argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026
February 19, 2026
From
argenx SE
Via
GlobeNewswire
Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash
↗
February 17, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million
↗
February 17, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Structure Therapeutics Stock Up 187% in One Year as Fund Trims $8 Million From Stake
↗
February 17, 2026
Via
The Motley Fool
Kymera Therapeutics Stock Up 120% in 1 Year as Fund Adds $3 Million More
↗
February 17, 2026
Via
The Motley Fool
Roivant Sciences (ROIV): Anatomy of a 15% Surge and the Future of the ‘Vant’ Model
February 06, 2026
Via
Finterra
Topics
ETFs
Economy
Initial Public Offering
Frequently Asked Questions
Is argenx SE - American Depositary Shares publicly traded?
Yes, argenx SE - American Depositary Shares is publicly traded.
What exchange does argenx SE - American Depositary Shares trade on?
argenx SE - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for argenx SE - American Depositary Shares?
The ticker symbol for argenx SE - American Depositary Shares is ARGX on the Nasdaq Stock Market
What is the current price of argenx SE - American Depositary Shares?
The current price of argenx SE - American Depositary Shares is 795.42
When was argenx SE - American Depositary Shares last traded?
The last trade of argenx SE - American Depositary Shares was at 05/19/26 03:17 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today